Current management of endometrial cancer

Contemporary Ob-Gyn

Volumn 43, Issue 12, 1998, Pages 86-97

  Finan, Michael A ^a   Kline, Richard C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012758812     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cancer Facts and Figures 1998. American Cancer Society, Atlanta, Georgia, 1998.
2. Varner RE, Sparks JM, Cameron CD, et al. Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol. 1991;78:195-199.
3. Brooks SE, Yeatts-Peterson M, Baker SP, et al. Thickened endometrial stripe and/or endometrial fluid as a marker of pathology: fact or fancy? Gynecol Oncol. 1996;63:19-24.
4. Kerpsack JT, Finan MA, Kline RC. Correlation between endometrial cells on Papanicolaou smear and endometrial carcinoma. South Med J. 1998;91:749-752.
5. Hunter JE, Tritz DE, Howell MG, et al. The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia. Gynecol Oncol. 1994; 55:66-71.
6. Janicek MF, Rosenshein NB. Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia. Gynecol Oncol. 1994;52:373-378.
7. Widra EA, Dunton CJ, McHugh M, et al. Endometrial hyperplasia and the risk of carcinoma. Int J Gynecol Cancer. 1995;5:233-235.
8. Randall TC, Kurman RJ. Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol. 1997;90:434-440.
9. Bokhman JV, Chepick OF, Volkova AT, et al. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol. 1985;20:139-155.
10. Kim YB, Holschneider CH, Ghosh K, et al. Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Cancer. 1997; 79:320-327.
11. Ferenczy A, Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol. 1989;160:126-131.
12. Farhi DC, Nosanchuk J, Silverberg SG. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol. 1986;68:741-745.
13. FIGO. Annual report on the results of treatment of gynecological cancer. Int J Gynaecol Obstet. 1989;28:189-190.
14. Cowles TA, Magrina JF, Masterson BJ, et al. Comparison of clinical and surgical-staging in patients with endometrial carcinoma. Obstet Gynecol. 1985; 66:413-416.
15. Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol. 1990;38:46-48.
16. Fanning J, Tsukada Y, Piver MS. Intraoperative frozen section diagnosis of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol. 1990;37:47-50.
17. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. Cancer. 1987;60:2035-2041.
18. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol Oncol. 1991;40:55-65.
19. Homesley HD, Kadar N, Barrett RJ, et al. Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am J Obstet Gynecol. 1992;167:1225-1230.
20. Leijon T, Rosenberg P, Boeryd B. Total abdominal hysterectomy and bilateral salpingo-oophorectomy. A sufficient treatment for patients with low risk endometrial carcinoma. Int J Gynecol Cancer. 1997;7:376-380.
21. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma: a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol. 1990;38:99-104.
22. Kadar N, Homesley HD, Malfetano JH. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. Gynecol Oncol. 1992;46:145-149.
23. Piver MS, Recio FO, Baker TR, et al. A prospective trial of progesterone therapy for malignant peritoneal cytology in patients with endometrial carcinoma. Gynecol Oncol. 1992;47:373-376.
24. Rosenberg P, Boeryd B, Simonsen E. A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer. Gynecol Oncol. 1993;48:32-37.